(a) Model of KBP (ribbon representation) displayed in experimental cryo-electron microscopy density. The N-terminal (olive) and C-terminal (gold) subdomains are separated by a linker region (black). …
(a) Gold-standard Fourier shell correlation (FSC) curves between independent masked, unmasked, phase-randomised, and corrected half-maps (Chen et al., 2013) of KBP as calculated by RELION v3.1 (Zivan…
The human KBP sequence (numbering above), with residues coloured by intra-species sequence identity as indicated in the key. The following species were included in the Clustal Omega multiple …
View of KBP’s LL, using the same KBP model subdomain colouring and representation as in Figure 1a and b. Only density for the LL is shown and a rough path for the LL is indicated with a solid black …
(a) Model of the KBP–KIF15_MD6S complex (ribbon representation) displayed in experimental cryo-electron microscopy density. The N-terminal (olive) and C-terminal (gold) subdomains and the linker …
(a) KIF15_MD6S MT-activated steady-state ATPase velocity plotted as a function of [MT]. Data were fit to a Michaelis–Menten kinetic (pink curve) yielding values for kcat = 2.9 ± 0.5 s−1 and K0.5,MT =…
(a) The crystallographic model of the KIF15_MD alone (PDB: 4BN2 Klejnot et al., 2014) was superimposed on the KIF15 region of the KBP–KIF15_MD6S complex, with the KIF15 part of the KBP–KIF15_MD6S …
(a) Gold-standard Fourier shell correlation (FSC) curves between independent masked, unmasked, phase-randomised, and corrected half-maps (Chen et al., 2013) of the KIF15_MD6S-MT complex as …
(a) The KIF15_MD alone crystal structure (PDB code:4BN2 Klejnot et al., 2014) is shown coloured by kinesin subdomain (as in Figure 3), fitted into the KBP–KIF15_MD6S complex cryo-electron microscopy …
(a–d) Comparison of (a) kinesin-binding protein (KBP)-KIF15_MD6S complex with other TPR-containing α-solenoids shown in blue, and binding peptide motifs shown in magenta or pink for helical and …
(a) Pseudo-atomic model of the KBP–KIF15_MD6S complex (ribbon representation) displayed in cryo-electron microscopy density, using the same viewpoint as Figure 2a, but with the KIF15_MD6S now …
Colouring and representation as in Figure 4. (a) A view showing α-helical pairs αHP1, αHP2, αHP3, αHP8, and αHP9 of KBP and the KIF15_MD6S coloured by subdomain as labelled. (b) Left zoomed region …
(a) Schematic depiction of the inducible peroxisome motility assay, with the kinesin motor domain fused to an FRB domain and PEX fused to an FKBP domain. Addition of rapalog (Rap) links FRB and FKBP …
Representative images of COS-7 cells expressing HA–KBP mutant constructs. Scale bar, 10 µm.
(a) Control pull-down experiment with bioGFP-EV, bioGFP-KIF1A_MDC or bioGFP-KIF15_MDC and HA–KBP showing that KBP interacts with KIF1A_MDC and KIF15_MDC, but not with bioGFP-EV. (b, c) Example of …
(a–c) Representative images of peroxisomes in COS-7 cells expressing KIF1A_MDC (a) or KIF15_MDC–FRB (b, c), PEX–mRFP–FKBP and HA (left panels) with addition of rapalog. Images were thresholded at …
(a) Sequence alignment of the tubulin-binding subdomain from kinesin motor domains, made using Clustal Omega multiple sequence alignment (Sievers et al., 2011). Residues are coloured according to …
(a, b) Representative images of COS-7 cells expressing KIF15_MDC–HA–FRB and PEX–mRFP–FKBP treated with rapalog for three hours and co-stained for (a) microtubules (rabbit anti-α-tubulin, 1:1000, …
The KBP-alone model was superimposed on the KBP–KIF15_MD6S model using UCSF Chimera’s matchmaker (Pettersen et al., 2004). A conformational morph movie was then generated in Chimera between the …
Model of the KBP–KIF15_MD6S complex (ribbon representation) displayed in experimental cryo-electron microscopy density. The N-terminal (olive) and C-terminal (gold) subdomains and the linker region …
Data collection, processing, and model refinement information for the kinesin-binding protein (KBP), KBP–KIF15_MD6S, and KIF15_MD6S–MT datasets.
KBP (EMDB: EMD-11338, PDB: 6ZPG) | KBP–KIF15_MD6S (EMDB: EMD-11339, PDB: 6ZPH) | KIF15_MD6S–MT (EMDB: EMD-11340, PDB: 6ZPI) | |
---|---|---|---|
Data collection and processing | |||
Pixel size (Å)* | 1.055, 1.043, or 1.047 | 1.047 | 1.39 |
Number of micrographs (collected, final)* | 9360, 7547 | 6497, 5138 | 214,202 |
Final particle number | 258,049 (81,628 of which on graphene oxide) | 7513 | 12,674 |
Map resolution (Å) FSC threshold† | 4.6 Independent half-map FSC 0.143 | 6.9 Independent half-map FSC 0.143 | 4.5 Independent half-map FSC 0.143 |
Refinement | |||
Refinement resolution (Å) CC_mask‡ | 4.6 0.64 | 6.9 0.74 | 6 0.60 |
Map sharpening B-factor (Å2) | −200 | −495 | −134 |
Model composition Nonhydrogen atoms Protein residues Ligands | 3808 610 0 | 6232 948 1 | 9420 1185 4 |
R.m.s. deviations§ Bond lengths (Å) Bond angles (°) | 0.01 0.96 | 0.01 1.07 | 0.08 0.17 |
Validation# MolProbity score Clashscore Poor rotamers (%) | 1.66 5.25 0.5% | 1.84 7.31 0.9% | 1.95 13.25 0.1% |
Ramachandran plot# Favoured (%) Allowed (%) Outliers (%) | 94.38 5.62 0 | 93.13 6.87 0 | 95.38 4.62 0 |
*Inclusive of all data collection sessions.
†The resolution value at the gold-standard Fourier Shell Correlation (FSC) 0.143 criterion between independently refined half-maps.
‡Cross-correlation provided by Phenix real-space refine (Afonine et al., 2018).
§Root-mean-square deviations of bond lengths or angles in the model.
#As defined by the MolProbity validation server (Chen et al., 2010).
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Gene (Homo sapiens) | KIAA1279 | GenBank | HGNC:23419 | |
Gene (Mus musculus) | KIF1A | GenBank | MGI:108391 | |
Gene (Mus musculus) | KIF15 | GenBank | MGI:1098258 | |
Strain, strain background (Escherichia coli) | BL21(DE3) | NEB | Cat. #: C2527H | Competent cells |
Strain, strain background (Escherichia coli) | BL21-Gold (DE3) | Agilent | Cat. #: 230130 | Competent cells |
Strain, strain background (Escherichia coli) | Rosetta2 (DE3) | Novagen | Cat. #: 71400 | Competent cells |
Cell line (Homo sapiens) | Human embryonic kidney 239T (HEK293T) | ATCC | CRL-3216 RRID:CVCL_0063 | |
Cell line (Cercopithecus aethiops) | Cercopithecus aethiops kidney (COS-7) | ATCC | CRL-1651 RRID:CVCL_0224 | |
Peptide, recombinant protein | Porcine tubulin (>99% pure) | Cytoskeleton Inc | Cat. #: T240 | |
Antibody | Anti-HA (mouse monoclonal) | Roche | Cat# 11666606001; RRID:AB_514506 | IF (1:500) |
Antibody | Anti-mouse IgG1, Alexa488 (goat polyclonal) | Thermo Fisher Scientific | Cat# A-21121, RRID:AB_2535764 | IF (1:400) |
Antibody | Anti-HA (mouse monoclonal) | Biolegend | Cat# 901533; RRID:AB_2801249 | WB (1:2000) |
Antibody | Anti-GFP (rabbit polyclonal) | Abcam | Cat# ab290; RRID:AB_303395 | WB (1:10000) |
Antibody | Anti-rabbit IgG antibody, IRDye 680LTconjugated (goat polyclonal) | LI-COR Biosciences | Cat# 827–11081; RRID:AB_10795015 | WB (1:20000) |
Antibody | Anti-mouse IgG antibody, IRDye 800CWconjugated (goat polyclonal) | LI-COR Biosciences | Cat# 827–08364; RRID:AB_10793856 | WB (1:15000) |
Recombinant DNA reagent | KBP (plasmid) | Kevenaar et al., 2016 | Described in Materials and methods | |
Recombinant DNA reagent | KIF1A_MD (plasmid) | Atherton et al., 2014 | Described in Materials and methods | |
Recombinant DNA reagent | KIF15_MD (plasmid) | This study | Described in Materials and methods | |
Recombinant DNA reagent | pebioGFP (plasmid) | van der Vaart et al., 2013 | N/A | Described in Materials and methods |
Recombinant DNA reagent | BirA coding vector (plasmid) | van der Vaart et al., 2013 | N/A | Described in Materials and methods |
Recombinant DNA reagent | GW1–PEX3–mRFP–FKBP1 (plasmid) | Kevenaar et al., 2016 | N/A | Described in Materials and methods |
Recombinant DNA reagent | β-actin–Kif1A_MDC–FRB (plasmid) | Kevenaar et al., 2016 | N/A | Described in Materials and methods |
Recombinant DNA reagent | β-actin–Kif15_MDC–FRB (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pebioGFP-Kif1A_MDC (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pebioGFP-Kif15_MDC (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L1 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L3 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L5 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L10 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L12 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L14 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L16 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L18 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L10+L12 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L10+L14 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_L12+L14 (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_αHP4a (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_αHP4b (plasmid) | This study | N/A | Described in Materials and methods |
Recombinant DNA reagent | pGW1–HA–KBP_αHP5a (plasmid) | This study | N/A | Described in Materials and methods |
Sequence-based reagent | KBP_fwd | This study | PCR primer for KBP mutants | TATTATTATGGCGCGCCAGGATCCCCGGAATTCGGCACGAGGGAGGCCGCTATGGCGAACGTTCCGTGGGCA |
Sequence-based reagent | KBP_rev | This study | PCR primer for KBP mutants | CTCGTCGACTCCTAATCCTTAAGTCAGGGCCATCTT |
Sequence-based reagent | KBP_L1_fwd | This study | PCR primer for KBP_L1 | CTGCATAAAAATCCGGCAGCAGCACCAGCAGCATCCAAATACAGCGCC |
Sequence-based reagent | KBP_L1_rev | This study | PCR primer for KBP_L1 | GGCGCTGTATTTGGATGCTGCTGGTGCTGCTGCCGGATTTTTATGCAG |
Sequence-based reagent | KBP_L3_fwd | This study | PCR primer for KBP_L3 | TGAACCACATCGACGCAGGAGGACTGTCGGCGGGGGA |
Sequence-based reagent | KBP_L3_rev | This study | PCR primer for KBP_L3 | TCCCCCGCCGACAGTCCTCCTGCGTCGATGTGGTTCA |
Sequence-based reagent | KBP_L5_fwd | This study | PCR primer for KBP_L5 | ATCTTGTGGTCTGAAGCAGGAGCAATTGAAACTGCACAG |
Sequence-based reagent | KBP_L5_rev | This study | PCR primer for KBP_L5 | CTGTGCAGTTTCAATTGCTCCTGCTTCAGACCACAAGAT |
Sequence-based reagent | KBP_L10_fwd | This study | PCR primer for KBP_L10 | TTTGGTCAAACTGGAGCAGGAGCAGGAGCAGGAGCAGGACCAGCAGGAGCAGGAGCAGGACCAGGAGGATATCATCAAAGAAA |
Sequence-based reagent | KBP_L10_rev | This study | PCR primer for KBP_L10 | TTTCTTTGATGATATCCTCCTGGTCCTGCTCCTGCTCCTGCTGGTCCTGCTCCTGCTCCTGCTCCTGCTCCAGTTTGACCAAA |
Sequence-based reagent | KBP_L12_fwd | This study | PCR primer for KBP_L12 | GAGTTCTTTCAGATTGGCGGCGCGGTCACTGACCATATT |
Sequence-based reagent | KBP_L12_rev | This study | PCR primer for KBP_L12 | AATATGGTCAGTGACCGCGCCGCCAATCTGAAAGAACTC |
Sequence-based reagent | KBP_L14_fwd | This study | PCR primer for KBP_L14 | TAGAGCCCCTAACTGTAGCAGCAGGACCAGCAGCATATCTGTTGGTCAAC |
Sequence-based reagent | KBP_L14_rev | This study | PCR primer for KBP_L14 | GTTGACCAACAGATATGCTGCTGGTCCTGCTGCTACAGTTAGGGGCTCTA |
Sequence-based reagent | KBP_L16_fwd | This study | PCR primer for KBP_L16 | TCCCTGAGAGACCCAGCAGCAGGAGCACCAGCAGGAGCAGGAGCAGGAGCAGCACGCCCTGCCATGTTA |
Sequence-based reagent | KBP_L16_rev | This study | PCR primer for KBP_L16 | TAACATGGCAGGGCGTGCTGCTCCTGCTCCTGCTCCTGCTGGTGCTCCTGCTGCTGGGTCTCTCAGGGA |
Sequence-based reagent | KBP_L18_fwd | This study | PCR primer for KBP_L18 | ATTGTTGATTACTGTGCAGCAGGACCAGGAGCCGCCCAGGAAATA |
Sequence-based reagent | KBP_L18_rev | This study | PCR primer for KBP_L18 | TATTTCCTGGGCGGCTCCTGGTCCTGCTGCACAGTAATCAACAAT |
Sequence-based reagent | KBP_HP4a_fwd | This study | PCR primer for KBP_L HP4a | ACTCATAACCTATATGCACTAGCTGCAGTCTACCAGCATCTG |
Sequence-based reagent | KBP_L HP4a _rev | This study | PCR primer for KBP_ HP4a | CAGATGCTGGTAGACTGCAGCTAGTGCATATAGGTTATGAGT |
Sequence-based reagent | KBP_HP4b_fwd | This study | PCR primer for KBP_L HP4b | AGTACACTAAAACGCGCACTTGAGCACAATGCC |
Sequence-based reagent | KBP_L HP4b _rev | This study | PCR primer for KBP_ HP4b | GGCATTGTGCTCAAGTGCGCGTTTTAGTGTACT |
Sequence-based reagent | KBP_HP5a_fwd | This study | PCR primer for KBP_L HP5a | GCTATCAATGCTGCTGCGTTGTCAGCGTTTTACATCAATAAG |
Sequence-based reagent | KBP_ HP5a _rev | This study | PCR primer for KBP_ HP5a | CTTATTGATGTAAAACGCTGACAACGCAGCAGCATTGATAGC |
Sequence-based reagent | KIF15_FRB_fwd | This study | PCR primer for KIF15–FRB | AAGCTTGCCACCATGGGCGCGCCTGCCACCATGGCTCCTGGCTGCAAATCT |
Sequence-based reagent | KIF15_FRB_rev | This study | PCR primer for KIF15–FRB | AGAGGATTCTAGAAGCAGGCGCGCCAGCGTAGTCTGGGACGTCGTATGGGTAGAATTCTCCTGGTGTCAGCTGCCCAGA |
Sequence-based reagent | bioGFPKIF15 _fwd | This study | PCR primer for bioGFPKIF15 | AGCTCAAGCTTCGAATTGGGCGCGCCAGCCACCATGGCTCCTGGCTGCAAATCT |
Sequence-based reagent | bioGFPKIF15_rev | This study | PCR primer for bioGFPKIF15 | GAATTCGATATCCTGCAGGTCGACTCCAGATCCTCATCCTGGTGTCAGCTGCCCAGA |
Sequence-based reagent | bioGFPKIF1A _fwd | This study | PCR primer for bioGFPKIF1A | TATTATAATGGCGCGCCAGCCACCGCCGGGGCCTCTGTGAAGGT |
Sequence-based reagent | bioGFPKIF1A_rev | This study | PCR primer for bioGFPKIF1A | CTCGTCGACTCCTCCTCCTCATTTGGGAGAAAACACACCCAA |
Commercial assay or kit | EnzChek Phosphate Assay Kit | Invitrogen | E6646 | |
Chemical compound, drug | AP21967 | TaKaRa | Cat# 635057 | 1 µM |
Chemical compound, drug | PEI | PolySciences | Cat# 24765–2 | |
Chemical compound, drug | Fugene | Promega | Cat# E2692 | |
Software, algorithm | ImageJ | NIH | https://imagej.nih.gov/ij/; RRID:SCR_003070 | |
Software, algorithm | RELION | Zivanov et al., 2018 | n/a | |
Software, algorithm | CryoSparc2 | Punjani et al., 2017 | n/a | |
Software, algorithm | CisTEM | Grant et al., 2018 | n/a | |
Software, algorithm | MiRP | Cook et al., 2020 | n/a | Protocol implemented in RELION |
The original and mutated amino acid (top) and nucleotide sequences (bottom) are shown for each construct.
Construct | Original sequence | Mutated to |
---|---|---|
L1 | EKEPYK gagaaggaaccatacaag | AAAPAA gcagcagcaccagcagca |
L3 | TEE acggaggag | AGG gcaggagga |
L5 | REE agagaagaa | AGA gcaggagca |
L10 | KISATEDTPEAEGEVPEL aagatctcagccacagaagacactcctgaagctgaaggagaagtgccagagctt | AGAGAGAGPAGAGAGPGG gcaggagcaggagcaggagcaggaccagcaggagcaggagcaggaccaggagga |
L12 | DGY gatggttat | GGA ggcggcgcg |
L14 | DLNPQY gacctgaatccacagtat | AAGPAA gcagcaggaccagcagca |
L16 | NKVFPEHIGEDVL aataaagtattccctgagcatataggggaagatgttctt | AAGAPAGAGAGAA gcagcaggagcaccagcaggagcaggagcaggagcagca |
L18 | EKHPE gaaaagcatcctgag | AAGPG gcagcaggaccagga |
αHP4a | YLAQ tacctagctcaa | ALAA gcactagctgca |
αHP4b | Q cag | A gca |
αHP5a | TLSQ accttgtcacag | ALSA gcgttgtcagcg |